Smoking Aids Do Help Quitting
Not everyone is able to quit smoking cold turkey, and that’s okay. There are several available types of quit smoking aids that have been proven to work over the years.
Smoking Cessation Meds: Take Two
Quitting smoking can be tough, but it simply has to be done. Researchers keep looking at ways to help people quit for good, even if there are side effects involved.
FDA Drug Safety Communication: Chantix Heart Risk
The US Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix (varenicline) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.
Meds & Counseling Combo Work Best
Quitting smoking is a life saving action. Don’t get down about it. Get help instead. Use support and medications together until the job is done.
Chantix Safe for Schizophrenics
A lot of people with schizophrenia smoke cigarettes. Clinically stable schizophrenics who took Chantix didn’t show an increase in symptoms, but they were more likely to quit smoking.
Chantix May Also Help With Drinking Problems
It might be possible to block pleasure receptors for both smoking and drinking with one pharmaceutical swoop. Heavy drinkers report drinking less alcohol after taking the anti-smoking drug— Chantix . Researchers took a drug already out on the market for smoking cessation and tried it on smokers who also drink heavily. The reduction in drinking was quite promising. Talk to your doctor if you think you have a drinking problem Jennifer Mitchell PhD, assistant professor of neurology at the University of California at San Francisco, led a study to understand the smoking cessation d...
FDA Safety Communication: Chantix
The U.S. Food and Drug Administration (FDA) has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking cessation drug Chantix ( varenicline ).
FDA: Chantix (varenicline) May Increase Cardiovascular Risk
The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix ( varenicline ) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.